Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Myelin in cartilaginous fish.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) in the Italian population.
Multiple Sclerosis: Modulation of Toll-Like Receptor (TLR) Expression by Interferon-β Includes Upregulation of TLR7 in Plasmacytoid Dendritic Cells.
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
Trimesta (Oral Estriol)
Two endogenous retroviral loci appear to contribute to Multiple Sclerosis.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
A silver lining of neuroinflammation: Beneficial effects on myelination.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study.
Identification of naturally occurring Fatty acids of the myelin sheath that resolve neuroinflammation.
The absence of 25-hydroxyvitamin D3-1α-hydroxylase potentiates the suppression of EAE in mice by ultraviolet light.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
The nature of genetic susceptibility to multiple sclerosis: constraining the possibilities.
Interferon beta treatment of multiple sclerosis increases serum interleukin-7.
The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Teriflunomide in multiple sclerosis: Added benefit not proven
Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.
Pages
« first
‹ previous
…
40
41
42
43
44
45
46
47
48
…
next ›
last »